نتائج البحث

Axillary Reverse Mapping Improves Quality of Life by Significantly Reducing Clinically Relevant Lymphedema After Axillary Lymph Node Dissection in Older Women with Breast Cancer.

• Authors : Tokocin M; Department of General Surgery, University of Health Sciences Türkiye, Istanbul Bacılar Training and Research Hospital, Istanbul 34100, Turkey.; Pehlivan T

Subjects: Lymph Node Excision*/Lymph Node Excision*/Lymph Node Excision*/adverse effects ; Lymph Node Excision*/Lymph Node Excision*/Lymph Node Excision*/methods ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2026 Apr 10; Vol. 33 (4). Date of Electronic Publication: 2026 Apr 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

The Effectiveness of Prophylactic Compression Sleeves in Reducing the Risk of Lymphedema in Patients Who Receive Breast Cancer Surgery: A Systematic Review.

• Authors : Shahid S; Department of Surgery, St. Josephs Hospital, London, ON N6A 4V2, Canada.; Moerahoe A

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery ; Lymphedema*/Lymphedema*/Lymphedema*/prevention & control ; Lymphedema*/Lymphedema*/Lymphedema*/etiology

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Nov 25; Vol. 32 (12). Date of Electronic Publication: 2025 Nov 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

• Authors : Kumar A; BC Cancer-Surrey, University of British Columbia, Vancouver, BC V3V 1Z2, Canada.; Jerzak KJ

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2026 Mar 31; Vol. 33 (4). Date of Electronic Publication: 2026 Mar 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

[Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)].

• Authors : China Anti-Cancer Association, Breast Cancer Professional Committee; Maternal and Child Health Research Society of China, Breast Cancer Prevention and Treatment Research Professional Committee

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/adverse effects ; Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2026 Mar 23; Vol. 48 (3), pp. 325-344.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766

تفاصيل العنوان

[Consensus on clinical diagnosis and treatment of breast cancer with low expression and ultralow expression of HER-2 (2025 edition)].

• Authors : China Anti-Cancer Association, Breast Cancer Professional Committee; Maternal and Child Health Research Society of China, Breast Cancer Prevention and Treatment Research Professional Committee

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnosis ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2026 Mar 23; Vol. 48 (3), pp. 345-358.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766

تفاصيل العنوان

Impact of a self management mobile application on quality of life and limb circumference in women with breast cancer related lymphedema.

• Authors : Hemati M; Student Research Committee, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.; Community Based Psychiatric Care Research Center, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.

Subjects: Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/diagnosis ; Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/psychology ; Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/therapy

• Source: Scientific reports [Sci Rep] 2025 Aug 18; Vol. 15 (1), pp. 30172. Date of Electronic Publication: 2025 Aug 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

The efficacy of immediate lymphatic reconstruction in preventing breast cancer-related lymphedema: long-term follow-up study.

• Authors : Kim KJ; Department of Plastic and Reconstructive Surgery, Korea University Hospital, Seoul, Republic of Korea.; Kim SH

Subjects: Lymph Node Excision*/Lymph Node Excision*/Lymph Node Excision*/adverse effects ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/surgery ; Lymphedema*/Lymphedema*/Lymphedema*/prevention & control

• Source: Journal of plastic surgery and hand surgery [J Plast Surg Hand Surg] 2025 Jun 25; Vol. 60, pp. 138-143. Date of Electronic Publication: 2025 Jun 25.Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 101534130 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Topical tacrolimus for the amelioration of breast cancer-related lymphedema (TACLE Trial): a study protocol for a randomized, double-blind, placebo-controlled phase II/III trial.

• Authors : Hansen FG; Research Unit for Plastic Surgery, Odense University Hospital, Odense, Denmark. .; Clinical Institute, University of Southern Denmark, Odense, Denmark. .

Subjects: Tacrolimus*/Tacrolimus*/Tacrolimus*/administration & dosage ; Tacrolimus*/Tacrolimus*/Tacrolimus*/adverse effects ; Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/drug therapy

• Source: Trials [Trials] 2025 Apr 08; Vol. 26 (1), pp. 127. Date of Electronic Publication: 2025 Apr 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

Developing the Short-Form of Lymphedema Needs Questionnaire for Iranian Breast Cancer Patients.

• Authors : Kazemzadeh M; Department of Statistics and Information Technology, Isfahan University of Medical Sciences, Isfahan, Iran.; Olfatbakhsh A

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/complications ; Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/diagnosis ; Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/Breast Cancer Lymphedema*/etiology

• Source: Cancer medicine [Cancer Med] 2025 Apr; Vol. 14 (7), pp. e70832.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Zeste White 10 May Serve as a Prognostic Biomarker and Therapeutic Target for Human Breast Cancer.

• Authors : Bellah SF; Department of Pharmacy, Pabna University of Science and Technology, Pabna-6600, Bangladesh.; Hossen MA

• Source: Breast cancer : basic and clinical research [Breast Cancer Publisher: SAGE Publications Country of Publication: United States NLM ID: 101474356 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان